COVID-19 low cost medicine Dexamethasone approved for use in India

The Central government has approved the use of low-cost steroid medicine dexamethasone for the treatment of COVID-19 patients in India. This drug will be used only to treat patients with severe symptoms. British clinical trials had earlier found Dexamethasone to be effective against severely ill COVID-19 patients. 

from IndiaTV India: Google News Feed https://ift.tt/2Zh3Vx1
via IFTTT

Comments

Popular posts from this blog

рд╢्рд░ीрд▓ंрдХा рдХे рд░ाрд╖्рдЯ्рд░рдкрддि рдЧोрдЯрдмाрдпा рднाрд░рдд рдкрд╣ुंрдЪे, рдЖрдЬ рдХрд░ेंрдЧे рдкीрдПрдо рдоोрджी рдХे рд╕ाрде рдмाрддрдЪीрдд

PM рдоोрджी рдХो рд▓ेрдХрд░ рдЖрдкрдд्рддिрдЬрдирдХ рдЯिрдк्рдкрдгी рдкрд░ рдоुрдо्рдмрдИ рдХी рдЕрджाрд▓рдд рдиे рд░ाрд╣ुрд▓ рдЧांрдзी рдХो рднेрдЬा рд╕рдорди

рджिрд▓्рд▓ी: рдирдЧрд░ рдиिрдЧрдо рдиे рд╕ोрд╕ाрдЗрдЯी рдХे рдЧेрдЯ рддुрдб़рд╡ाрдП, AAP рдмोрд▓ी- рдлिрд░ рд╕े рд▓рдЧрд╡ाрдПंрдЧे